Medicines
How long will you be on goserelin?
The length of goserelin treatment depends on why it was started. After surgery it is often given for up to five years alongside a hormone tablet. To protect the ovaries it is given only during chemotherapy. For advanced disease it continues while it helps. This page explains each pattern, when length is reviewed and what happens when goserelin ends.
On this page
- How long goserelin is usually given
- Four reasons for goserelin, four different lengths
- Moments when the length of treatment is often discussed
- Terms about treatment length, in plain language
- What is still uncertain about treatment length
- What often comes next
- If you want to stop goserelin sooner
- What people assume about how long goserelin lasts
- Common questions about the length of goserelin treatment
The short answer
How long goserelin is usually given
How long you stay on goserelin (Zoladex) depends mainly on why it was started. For premenopausal women with hormone receptor positive early breast cancer who are at higher risk of the cancer returning, goserelin is usually given alongside tamoxifen or an aromatase inhibitor for up to five years. That is the length used in the large trials that showed a benefit, and it is what most guidelines describe. Some teams use a shorter course, such as two or three years, particularly when side effects are hard to live with or the benefit is expected to be smaller, and that is a reasonable conversation to have. When goserelin is given only to help protect the ovaries during chemotherapy, it is started shortly before chemotherapy and stopped when chemotherapy finishes, so the course lasts a matter of months. For advanced breast cancer, goserelin is usually continued for as long as the hormone treatment it supports is controlling the cancer and you are coping with it, which may be many months or years. If the partner medicine changes, goserelin often continues so the ovaries stay switched off. As you approach the usual age of natural menopause, your team may review whether it is still needed. Whatever the plan, the length should be agreed with your oncologist and revisited over time.
Early breast cancer: often up to five years
Goserelin is usually given for the same period as the hormone tablet it is paired with, or less.
Ovary protection: during chemotherapy only
It starts before chemotherapy and ends when chemotherapy ends.
Advanced disease: as long as it helps
Treatment continues while the cancer is controlled and side effects are manageable.
These are general patterns. Your oncologist will set and review the length of your own treatment.Different situations
Four reasons for goserelin, four different lengths
The purpose of treatment shapes the plan more than anything else.
After surgery, higher risk
Usually up to five years, alongside tamoxifen or an aromatase inhibitor, with regular reviews of side effects and benefit.
Protecting the ovaries
Started shortly before the first chemotherapy and continued until chemotherapy finishes.
This is separate from any later decision about hormone treatment.Advanced breast cancer
Continued as long as the cancer is controlled, often through several changes of partner medicine.
Men with breast cancer
Usually given for as long as the aromatase inhibitor it supports.
Things that may change the plan
- Side effects that cannot be managed
- A wish to try for a pregnancy
- Reaching natural menopause age
Review points
Moments when the length of treatment is often discussed
Words you will hear
Terms about treatment length, in plain language
- Adjuvant treatment
- Treatment given after surgery to lower the chance of the cancer returning.
- Extended hormone therapy
- Continuing hormone tablets beyond five years for some people at higher risk.
- Ovarian function suppression
- Switching off the ovaries with medicines such as goserelin.
- Treatment duration
- The total length of time a treatment is given.
- Progression
- When advanced cancer grows or spreads despite treatment.
- Menopausal status
- Whether your ovaries are still working, which affects which hormone tablets suit you.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Being straight with you
What is still uncertain about treatment length
The ideal length of ovarian suppression is not settled for everyone, and it is fair to say so.
Trials tested set lengths
Most of the evidence comes from studies that gave ovarian suppression for five years, while others used two. Direct comparisons of different lengths are limited.
Benefit and burden both build up
Longer treatment may add protection for higher-risk women, but side effects also accumulate over the years.
Stopping early is common
Many women find the years on ovarian suppression hard. Stopping early should be a shared decision rather than a quiet one.
What this page cannot tell you
It cannot tell you the right length of treatment for you. That depends on your risk, how you are coping and your plans, which your oncologist can weigh with you.
After goserelin ends
What often comes next
Stopping goserelin does not always mean stopping all hormone treatment.
If you are still premenopausal
Your ovaries may start working again. If further hormone treatment is advised, tamoxifen is usually used, because aromatase inhibitors do not work well while the ovaries are active.
If you have reached menopause
Your team may use blood tests over time to check whether your ovaries have stopped for good. If they have, an aromatase inhibitor may be considered for extended treatment.
Bone and wellbeing checks
A repeat bone scan and a review of how you are feeling are sensible as treatment ends.
Thinking of stopping?
If you want to stop goserelin sooner
Wanting to stop is understandable, and there are usually options to discuss.
Talk first
Your team can explain how much extra benefit you might be giving up, and whether side effects can be eased with other help.
Consider alternatives
Switching from an aromatase inhibitor to tamoxifen, shortening the planned course, or choosing surgery to remove the ovaries are all possible paths for some women.
Pregnancy wishes
Some women pause hormone treatment to try for a baby after discussion with their oncologist, then restart.
Commonly believed
What people assume about how long goserelin lasts
For early breast cancer it has a planned end, usually within five years.
The extra benefit of longer treatment depends on risk and must be weighed against side effects.
A hormone tablet may continue after goserelin ends.
Time on treatment still counts. Your team can explain what stopping sooner means for you.
Questions we are asked
Common questions about the length of goserelin treatment
Why five years?
Five years is the length tested in the main trials of ovarian suppression for early breast cancer, and it matches the usual length of hormone tablets. Because it was the length studied, it is the standard most guidelines refer to. Shorter courses are sometimes used when the balance of benefit and side effects favours it.
Can I stop goserelin at two years?
Some studies used two years of ovarian suppression and found a benefit, so a shorter course may be reasonable for some women. It depends on your risk and how you are coping. Discuss it with your oncologist rather than stopping on your own.
Will I need goserelin after I turn fifty?
As you reach the usual age of natural menopause, your team may review whether goserelin is still needed. Because goserelin masks whether your ovaries would have stopped on their own, this can take careful planning and blood tests over time.
What happens to my periods when I stop?
If your ovaries recover, periods usually return within some months of the last implant. For women close to natural menopause, or who had chemotherapy, periods may not return. Use contraception if you do not want to become pregnant.
How long does goserelin keep working after the last implant?
Each implant lasts about four weeks. After that, hormone levels begin to recover over the following weeks to months. The pace varies with age and past treatment, so do not assume you cannot become pregnant soon after stopping.
Is the course longer for advanced breast cancer?
Usually yes. There is no fixed end date. Goserelin generally continues while hormone treatment is controlling the cancer, and may continue with a new partner medicine if the cancer grows. Your team will review it at each change in treatment.
Can I switch to surgery partway through?
Yes, some women choose keyhole surgery to remove the ovaries instead of continuing monthly implants. It is permanent and means no chance of natural pregnancy afterwards, so it needs careful thought and a conversation with your oncologist and a gynaecologist.
Does a break in treatment reset the five years?
Not usually. Short breaks, for example to try for a pregnancy, are counted differently by different teams, and treatment often resumes to complete the planned course. Ask your oncologist how any break would be handled in your case.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Sources
- Cancer Research UK — Goserelin (Zoladex)
- ASCO — Ovarian suppression for breast cancer guideline
- Breast Cancer Now — Ovarian suppression
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.